Not applicableStudy completedNCT06489704
What this trial is testing
High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)
Who this might be right for
High Altitude Pulmonary Hypertension
University of Zurich 24